Predictive Biomarker Guides Prostate Cancer Hormone Therapy

Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 BALANCE trial. Medscape Medical News

Read the full article on medscape.com